melanoma surgeon, surgical educator, father, husband and fisherman
Joined February 2014
- Tweets 2,608
- Following 470
- Followers 1,057
- Likes 2,816
122 Photos and videos
Keith Delman retweeted
10 May 2025
New weekly @AnnSurgOncol featured article: Short-term Patient-Reported Outcomes Following Bilateral Risk-Reducing Mastectomy for Patients at a High Risk for Breast Cancer: A Systematic Review.
ow.ly/3Lwi50VCXJG #ASOFeaturedArticle
3
10
2,814
Keith Delman retweeted
9 May 2025
👏👏👏
9 May 2025
Honored to present our work on gender and seniority bias in surgical resident evaluations at #ASE2025. Grateful for the chance to engage with such a thoughtful and inspiring community @EmorySurgery @Surg_Education
4
9
1,744
Keith Delman retweeted
9 May 2025
#AudioVisualAbstract : Results of a Randomized Clinical Study of #Gemcitabine Plus Nab-Paclitaxel Versus Gemcitabine Plus S-1 as Neoadjuvant Chemotherapy for Resectable and Borderline Resectable #Pancreatic #DuctalAdenocarcinoma
rdcu.be/eloqh
@SyedAAhmad5
9
20
1,765
Keith Delman retweeted
7 May 2025
May Issue: Identification of Predictive Factors for the Development of In-Transit Metastasis in Patients with #Melanoma . @OlofssonBagge @C_ODonoghueMD @alabama_surgonc @MarkFariesMD @jzager99
rdcu.be/ekVZg
@DorianGarciaMD
@SyedAAhmad5
7
16
2,765
Keith Delman retweeted
7 May 2025
#AudioVisualAbstract : Implementation of the Targeted Axillary Dissection Procedure in Clinically Node-Positive #BreastCancer : A Retrospective Analysis
rdcu.be/ek3b4
@belenmerck
@SyedAAhmad5
4
6
1,171
Keith Delman retweeted
8 May 2025
May Issue: Clinical Significance of Coiled-Coil Domain-Containing Protein 25 Expression in #Esophageal #SquamousCellCarcinoma
rdcu.be/ek3eF
@lindSLUe
@SyedAAhmad5
3
2
1,489
Keith Delman retweeted
8 May 2025
Featured: Strategies for Recurrent #ColorectalLiver Metastases Based on Prognostic Factors and Resectability: Potential Benefit of #MultidisciplinaryTreatment . @Kosuke_Koba_yh8
ow.ly/z35w50VON9C
@_BrainyMD_
@SyedAAhmad5
4
10
1,149
Keith Delman retweeted
8 May 2025
#AudioVisualAbstract : Endoscopic Evaluation of #PathologicalCompleteResponse Using #DeepNeuralNetwork in #EsophagealCancer Patients Who Received Neoadjuvant Chemotherapy—Multicenter Retrospective Study from Four Japanese Esophageal Centers
rdcu.be/elfqy
@SyedAAhmad5
3
6
1,236
Keith Delman retweeted
18 Apr 2025
Thank you for your excellent talks and for sharing your experiences with our residents in rocking chair rounds!
18 Apr 2025
Enjoyed being back in my “home” #BeanTown #Boston as combined @MGHSurgery @MGHCancerCenter Visiting Professor. ❤️seeing old friends & mentors, as well as spending time with next generation of #surgical #leaders. Big 🙏 to Dr. Lillemoe for being as kind & gracious as always. 🎁
4
40
5,253
Keith Delman retweeted
17 Apr 2025
Join us on April 22, 2025, for the Emory at Grady Faculty Awards. This ceremony will recognize outstanding faculty contributions and achievements. Hope to see you there!279
1
180
Keith Delman retweeted
18 Apr 2025
April Issue: Risk-Prediction Models for Clinical Decision-Making in #Sarcoma Care: An International Survey Among Soft-Tissue Sarcoma Clinicians @lvanbodegomvos
rdcu.be/ehSLh
@DorianGarciaMD
@SyedAAhmad5
8
11
2,525
5 Mar 2025
.@EmoryMedicine @EmoryatGrady @emorygradydoc @grannysurgeon @EmorySurgery This year’s SURG-20 class. Notice something special? Yep! All women. Truly an honor to teach these amazing future doctors @wiserpodcast
2
3
25
3,191
Keith Delman retweeted
10 Nov 2024
The latest SSO consensus statement urges caution with gene expression profiling (GEP) for primary cutaneous melanoma. Given evolving evidence, GEP is recommended as an investigational tool in research or clinical trials. Read more: @AnnSurgOncol: surgonc.org/annals-of-surgic…
7
8
2,728
Keith Delman retweeted
10 Nov 2024
I get asked how GEP tests should be used in cutaneous melanoma at every meeting. Great to see this consensus statement out in print. @SocSurgOnc
10 Nov 2024
The latest SSO consensus statement urges caution with gene expression profiling (GEP) for primary cutaneous melanoma. Given evolving evidence, GEP is recommended as an investigational tool in research or clinical trials. Read more: @AnnSurgOncol: surgonc.org/annals-of-surgic…
1
9
1,222
Keith Delman retweeted
30 Oct 2024
SSO announces publication of its 1st consensus statement, Assessing the Evidence For and Utility of Gene Expression Profiling of Primary Cutaneous Melanoma. Developed by melanoma specialists around four clinical questions on GEP testing for primary CM. ow.ly/OSAa50TWrhM
5
12
1,406
27 Jul 2024
.@EmoryMedicine @WinshipAtEmory @GradyHealth @emorygradydoc Marti Russell debating Dr. Jordan Berlin pros and cons of neoadjuvant therapy for pancreas cancer making us proud!! #DDHO2024
6
23
1,198
Keith Delman retweeted
14 Jun 2024
We are pleased to announce that Oliver Eng, MD, has been selected to serve as new Associate Editor for the Gastrointestinal Surgery section of JSR. Dr. Eng is an Associate Professor of Clinical Surgery in the Division of Surgical Oncology @UCIrvineSurgery.
10
15
70
5,252
Keith Delman retweeted
16 Jun 2024
Best job in the 🌎🌍🌏….being a dad to these great kids. Happy #FathersDay2024 to all the dads out there. Hug them twice as hard today! #BlessedAndGrateful
1
1
29
3,154
Keith Delman retweeted
16 Jun 2024
Enjoyed celebrating our wonderful Emory General Surgery Chief Residents graduate last night with my friend and mentor @aa_chahine Congrats to all!! @EmorySurgery @EdLinEmory @emorygradydoc @falco__e @JsharmaSharma
2
10
521